All Stories

  1. The decline of rate and mortality of acute myocardial infarction. Almost there, still a long way to go
  2. Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial